Lanean...
Preclinical Evaluation of Artesunate as an Antineoplastic Agent in Ovarian Cancer Treatment
Background: Ovarian cancer is the deadliest gynecologic malignancy despite current first-line treatment with a platinum and taxane doublet. Artesunate has broad antineoplastic properties but has not been investigated in combination with carboplatin and paclitaxel for ovarian cancer treatment. Method...
Gorde:
| Argitaratua izan da: | Diagnostics (Basel) |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7996621/ https://ncbi.nlm.nih.gov/pubmed/33652561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics11030395 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|